Literature DB >> 11923062

Fast dispersible ibuprofen tablets.

Simone Schiermeier1, Peter Christian Schmidt.   

Abstract

Fast dispersible tablets disintegrate either rapidly in water, to form a stabilized suspension, or disperse instantaneously in the mouth to be swallowed without the aid of water. A direct compression method was used to prepare these two types of tablets containing coated ibuprofen as a high dosed model drug. The properties of the water dispersible tablet, such as porosity, hardness, disintegration time and increase in viscosity after dispersion, were investigated. The selected tablet formulation, containing 26% galactomannan and 5% crospovidone, disintegrates before the galactomannan starts to swell. These tablets disperse in water within 40 s and show a crushing strength of 95 N. To develop an orodispersible tablet, a rotatable central composite design was applied to predict the effects of the quantitative factors mannitol and crospovidone as well as compression force on the characteristics of the tablet. Special emphasis was paid to the development of a wetting test, replacing the normal disintegration method. An optimum tablet formulation, containing 34% mannitol and 13% crospovidone, provides a short wetting time of 17 s and a sufficient crushing strength of 40 N. In conclusion, fast dispersible tablets with acceptable hardness and desirable taste could be prepared within the optimum region.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923062     DOI: 10.1016/s0928-0987(02)00011-8

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  28 in total

1.  Design of rapidly disintegrating oral tablets using acid-treated yeast cell wall: a technical note.

Authors:  Tetsuya Ozeki; Yuriko Yasuzawa; Hideyo Katsuyama; Yuuki Takashima; Takahide Kasai; Takahiro Eguchi; Hisaya Kakiuchi; Hiroshi Yuasa; Hiroaki Okada
Journal:  AAPS PharmSciTech       Date:  2003-12-31       Impact factor: 3.246

2.  Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aid.

Authors:  Satishkumar P Jain; Dharmini C Mehta; Sejal P Shah; Pirthi Pal Singh; Purnima D Amin
Journal:  AAPS PharmSciTech       Date:  2010-05-25       Impact factor: 3.246

3.  Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.

Authors:  Mutasem M Rawas-Qalaji; F Estelle R Simons; Keith J Simons
Journal:  AAPS PharmSciTech       Date:  2006-04-28       Impact factor: 3.246

4.  Critical Tools in Tableting Research: Using Compaction Simulator and Quality by Design (QbD) to Evaluate Lubricants' Effect in Direct Compressible Formulation.

Authors:  Nailla Jiwa; Yildiz Ozalp; Gizem Yegen; Buket Aksu
Journal:  AAPS PharmSciTech       Date:  2021-05-11       Impact factor: 3.246

5.  Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin.

Authors:  Jashanjit Singh; Anil K Philip; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2008-01-09       Impact factor: 3.246

6.  Modified polysaccharides as fast disintegrating excipients for orodispersible tablets of roxithromycin.

Authors:  Vijay Sharma; Anil K Philip; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2008-01-15       Impact factor: 3.246

7.  Pediatric Dispersible Tablets: a Modular Approach for Rapid Prototyping.

Authors:  Jonas Buck; Jörg Huwyler; Peter Kühl; Angela Dischinger
Journal:  Pharm Res       Date:  2016-06-01       Impact factor: 4.200

8.  A novel approach to optimize and formulate fast disintegrating tablets for nausea and vomiting.

Authors:  Honey Goel; Nishant Vora; Vikas Rana
Journal:  AAPS PharmSciTech       Date:  2008-06-27       Impact factor: 3.246

9.  Development of fast dispersible aceclofenac tablets: effect of functionality of superdisintegrants.

Authors:  C Mallikarjuna Setty; D V K Prasad; V R M Gupta; B Sa
Journal:  Indian J Pharm Sci       Date:  2008 Mar-Apr       Impact factor: 0.975

10.  Development of mouth dissolving tablets of clozapine using two different techniques.

Authors:  R S Masareddy; R V Kadia; F V Manvi
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.